Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 111.5 | 58 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 107.0 | 63 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 217.5 | 66 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 115.0 | 58 | |
| N2586 | Visfatin | 1 | ng/mL | 3 | RANTES | 110.0 | 60 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 332.5 | 70 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 80.0 | 55 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 117.0 | 49 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 198.0 | 68 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | RANTES | 202.5 | 68 | |
| RA2159 | Leptin | 1 | ng/mL | 3 | RANTES | 170.0 | 61 | ||||
| RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 126.0 | 72 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 45.5 | 70 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 119.0 | 57 | |
| RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 70.5 | 68 | |
| RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 128.0 | 65 | |
| N2586 | Leptin | 1 | ng/mL | 3 | RANTES | 109.0 | 85 | ||||
| N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 148.0 | 65 | |
| N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 182.0 | 63 | |
| N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 66.5 | 72 | |
| N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 84.0 | 65 | |
| N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | RANTES | 96.5 | 64 | |
| RA2159 | Adiponectin | 5 | ng/mL | 3 | RANTES | 91.0 | 65 | ||||
| RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | RANTES | 80.0 | 87 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | RANTES | 150.0 | 81 |